Characterization of the Anti-Biofilm and Anti-Quorum Sensing Activities of the β-Adrenoreceptor Antagonist Atenolol against Gram-Negative Bacterial Pathogens

• Published in: International journal of molecular sciences Vol. 23; no. 21; p. 13088
• Main Authors: Cavalu, Simona, Elbaramawi, Samar S., Eissa, Ahmed G., Radwan, Mohamed F., S. Ibrahim, Tarek, Khafagy, El-Sayed, Lopes, Bruno Silvester, Ali, Mohamed A. M., Hegazy, Wael A. H., Elfaky, Mahmoud A.
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.11.2022; MDPI
• Subjects: Adrenergic receptors; Amino acids; anti-biofilm; Antibiotics; Antimicrobial agents; antimicrobial resistance; Atenolol; Bacteria; Biofilms; Gram-negative; Gram-negative bacteria; Hydrogen bonds; Ligands; Pathogens; Proteins; Proteus mirabilis; Pseudomonas aeruginosa; Public health; Quorum sensing; Serratia marcescens; Simulation; Virulence
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms232113088

The development of bacterial resistance to antibiotics is an increasing public health issue that worsens with the formation of biofilms. Quorum sensing (QS) orchestrates the bacterial virulence and controls the formation of biofilm. Targeting bacterial virulence is promising approach to overcome the resistance increment to antibiotics. In a previous detailed in silico study, the anti-QS activities of twenty-two β-adrenoreceptor blockers were screened supposing atenolol as a promising candidate. The current study aims to evaluate the anti-QS, anti-biofilm and anti-virulence activities of the β-adrenoreceptor blocker atenolol against Gram-negative bacteria Serratia marcescens, Pseudomonas aeruginosa, and Proteus mirabilis. An in silico study was conducted to evaluate the binding affinity of atenolol to S. marcescens SmaR QS receptor, P. aeruginosa QscR QS receptor, and P. mirabilis MrpH adhesin. The atenolol anti-virulence activity was evaluated against the tested strains in vitro and in vivo. The present finding shows considerable ability of atenolol to compete with QS proteins and significantly downregulated the expression of QS- and virulence-encoding genes. Atenolol showed significant reduction in the tested bacterial biofilm formation, virulence enzyme production, and motility. Furthermore, atenolol significantly diminished the bacterial capacity for killing and protected mice. In conclusion, atenolol has potential anti-QS and anti-virulence activities against S. marcescens, P. aeruginosa, and P. mirabilis and can be used as an adjuvant in treatment of aggressive bacterial infections.